Delayed
Japan Exchange
10:15:43 17/05/2024 am IST
|
5-day change
|
1st Jan Change
|
1,400
JPY
|
0.00%
|
|
-1.41%
|
+10.15%
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,476
|
1,284
|
1,163
|
1,604
|
1,813
|
1,741
|
Enterprise Value (EV)
1 |
3,559
|
3,886
|
3,544
|
3,489
|
4,074
|
3,953
|
P/E ratio
|
8.84
x
|
8.79
x
|
19.7
x
|
5.71
x
|
8.32
x
|
6.83
x
|
Yield
|
-
|
2.85%
|
3.14%
|
3.8%
|
3.36%
|
3.5%
|
Capitalization / Revenue
|
0.19
x
|
0.17
x
|
0.18
x
|
0.2
x
|
0.22
x
|
0.2
x
|
EV / Revenue
|
0.47
x
|
0.52
x
|
0.53
x
|
0.44
x
|
0.49
x
|
0.46
x
|
EV / EBITDA
|
6.59
x
|
6.82
x
|
7.51
x
|
4.6
x
|
5.9
x
|
5.21
x
|
EV / FCF
|
-6.2
x
|
-5.94
x
|
15
x
|
7.31
x
|
-15.3
x
|
59.3
x
|
FCF Yield
|
-16.1%
|
-16.8%
|
6.66%
|
13.7%
|
-6.55%
|
1.69%
|
Price to Book
|
0.8
x
|
0.66
x
|
0.59
x
|
0.71
x
|
0.75
x
|
0.66
x
|
Nbr of stocks (in thousands)
|
1,218
|
1,218
|
1,218
|
1,218
|
1,218
|
1,217
|
Reference price
2 |
1,212
|
1,054
|
955.0
|
1,317
|
1,489
|
1,430
|
Announcement Date
|
27/02/19
|
27/02/20
|
25/02/21
|
24/02/22
|
24/02/23
|
22/02/24
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
7,605
|
7,488
|
6,628
|
7,939
|
8,368
|
8,610
|
EBITDA
1 |
540
|
570
|
472
|
758
|
690
|
759
|
EBIT
1 |
243
|
193
|
81
|
381
|
294
|
354
|
Operating Margin
|
3.2%
|
2.58%
|
1.22%
|
4.8%
|
3.51%
|
4.11%
|
Earnings before Tax (EBT)
1 |
222
|
198
|
82
|
393
|
282
|
341
|
Net income
1 |
167
|
146
|
59
|
281
|
218
|
255
|
Net margin
|
2.2%
|
1.95%
|
0.89%
|
3.54%
|
2.61%
|
2.96%
|
EPS
2 |
137.1
|
119.9
|
48.45
|
230.8
|
179.0
|
209.5
|
Free Cash Flow
1 |
-573.6
|
-654.1
|
236
|
477.5
|
-266.9
|
66.62
|
FCF margin
|
-7.54%
|
-8.74%
|
3.56%
|
6.01%
|
-3.19%
|
0.77%
|
FCF Conversion (EBITDA)
|
-
|
-
|
50%
|
62.99%
|
-
|
8.78%
|
FCF Conversion (Net income)
|
-
|
-
|
400%
|
169.93%
|
-
|
26.13%
|
Dividend per Share
|
-
|
30.00
|
30.00
|
50.00
|
50.00
|
50.00
|
Announcement Date
|
27/02/19
|
27/02/20
|
25/02/21
|
24/02/22
|
24/02/23
|
22/02/24
|
Fiscal Period: November |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,083
|
2,602
|
2,381
|
1,885
|
2,261
|
2,212
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.857
x
|
4.565
x
|
5.044
x
|
2.487
x
|
3.277
x
|
2.914
x
|
Free Cash Flow
1 |
-574
|
-654
|
236
|
478
|
-267
|
66.6
|
ROE (net income / shareholders' equity)
|
9.34%
|
7.7%
|
3.01%
|
13.3%
|
9.35%
|
10.1%
|
ROA (Net income/ Total Assets)
|
2.32%
|
1.72%
|
0.7%
|
3.16%
|
2.27%
|
2.66%
|
Assets
1 |
7,191
|
8,512
|
8,435
|
8,899
|
9,619
|
9,601
|
Book Value Per Share
2 |
1,516
|
1,600
|
1,619
|
1,849
|
1,980
|
2,167
|
Cash Flow per Share
2 |
553.0
|
326.0
|
724.0
|
1,083
|
747.0
|
857.0
|
Capex
1 |
631
|
912
|
356
|
261
|
240
|
378
|
Capex / Sales
|
8.3%
|
12.18%
|
5.37%
|
3.29%
|
2.87%
|
4.39%
|
Announcement Date
|
27/02/19
|
27/02/20
|
25/02/21
|
24/02/22
|
24/02/23
|
22/02/24
|
|
1st Jan change
|
Capi.
|
---|
| +10.15% | 10.98M | | +4.96% | 105B | | -3.11% | 64.71B | | +74.29% | 49.72B | | +15.53% | 38.6B | | +5.11% | 32.54B | | +10.79% | 19.94B | | +13.07% | 16.92B | | +18.38% | 15.2B | | +4.83% | 14.39B |
Other Commodity Chemicals
|